A series of novel Acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors 8a-f was synthesized; the substances were characterized by the presence of a 2,5-dimethylpyrazin-3-yl moiety at one end and a 3-heptylamino-5- phenylpyridazine system at the other one, linked through linear alkyl spacers of different length. The new derivatives were designed based on the hypothesis that the 3-amino-5-phenylpyridazine moiety could mimic the aryl substituted urea, which was present in a number of ACAT inhibitors previously described. The choice of the 2,5-dimethylpyrazin-3-yl substituent was supported by a preliminary investigation, which indicated that this moiety is the most powerful in conferring ACAT inhibitory properties to the new series. The pharmacological results proved the idea to be sound. Finally, compounds 9a-c, lacking the phenylpyridazine moiety were prepared and tested to further strengthen our hypothesis.

Gelain, A., Barlocco, D., KWON Byong, M., JEONG Tae, S., IM Kyung, R., Legnani, L., et al. (2006). 3-Heptylamino-5-phenylpyridazine derivatives as analogues of acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N’-arylureidic moiety. ARCHIV DER PHARMAZIE, 339(12), 645-651 [10.1002/ardp.200600106].

3-Heptylamino-5-phenylpyridazine derivatives as analogues of acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N’-arylureidic moiety

LEGNANI, LAURA;
2006

Abstract

A series of novel Acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors 8a-f was synthesized; the substances were characterized by the presence of a 2,5-dimethylpyrazin-3-yl moiety at one end and a 3-heptylamino-5- phenylpyridazine system at the other one, linked through linear alkyl spacers of different length. The new derivatives were designed based on the hypothesis that the 3-amino-5-phenylpyridazine moiety could mimic the aryl substituted urea, which was present in a number of ACAT inhibitors previously described. The choice of the 2,5-dimethylpyrazin-3-yl substituent was supported by a preliminary investigation, which indicated that this moiety is the most powerful in conferring ACAT inhibitory properties to the new series. The pharmacological results proved the idea to be sound. Finally, compounds 9a-c, lacking the phenylpyridazine moiety were prepared and tested to further strengthen our hypothesis.
Articolo in rivista - Articolo scientifico
ACAT inhibitors; Hypercholesterolemia; Pyridazine derivatives; Ureido analogues;
English
645
651
7
Gelain, A., Barlocco, D., KWON Byong, M., JEONG Tae, S., IM Kyung, R., Legnani, L., et al. (2006). 3-Heptylamino-5-phenylpyridazine derivatives as analogues of acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N’-arylureidic moiety. ARCHIV DER PHARMAZIE, 339(12), 645-651 [10.1002/ardp.200600106].
Gelain, A; Barlocco, D; KWON Byong, M; JEONG Tae, S; IM Kyung, R; Legnani, L; Toma, L
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/352032
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact